Merck
  • 主页
  • 查找结果
  • Lectin-like oxidized low-density lipoprotein receptor-1 abrogation causes resistance to inflammatory bone destruction in mice, despite promoting osteoclastogenesis in the steady state.

Lectin-like oxidized low-density lipoprotein receptor-1 abrogation causes resistance to inflammatory bone destruction in mice, despite promoting osteoclastogenesis in the steady state.

Bone (2015-03-07)
Mai Nakayachi, Junta Ito, Chiyomi Hayashida, Yoko Ohyama, Akemi Kakino, Mari Okayasu, Takuya Sato, Toru Ogasawara, Toshio Kaneda, Naoto Suda, Tatsuya Sawamura, Yoshiyuki Hakeda
摘要

Inflammatory bone diseases have been attributed to increased bone resorption by augmented and activated bone-resorbing osteoclasts in response to inflammation. Although the production of diverse proinflammatory cytokines is induced at the inflamed sites, the inflammation also generates reactive oxygen species that modify many biological compounds, including lipids. Among the oxidized low-density lipoprotein (LDL) receptors, lectin-like oxidized LDL receptor-1 (LOX-1), which is a key molecule in the pathogenesis of multifactorial inflammatory atherosclerosis, was downregulated with osteoclast differentiation. Here, we demonstrate that LOX-1 negatively regulates osteoclast differentiation by basically suppressing the cell-cell fusion of preosteoclasts. The LOX-1-deleted (LOX-1(-/-)) mice consistently decreased the trabecular bone mass because of elevated bone resorption during the growing phase. In contrast, when the calvaria was inflamed by a local lipopolysaccharide-injection, the inflammation-induced bone destruction accompanied by the elevated expression of osteoclastogenesis-related genes was reduced by LOX-1 deficiency. Moreover, the expression of receptor activator of NF-κB ligand (RANKL), a trigger molecule for osteoclast differentiation, evoked by the inflammation was also abrogated in the LOX-1(-/-) mice. Osteoblasts, the major producers of RANKL, also expressed LOX-1 in response to proinflammatory agents, interleukin-1β and prostaglandin E2. In the co-culture of LOX-1(-/-) osteoblasts and wild-type osteoclast precursors, the osteoclastogenesis induced by interleukin-1β and prostaglandin E2 decreased; this process occurred in parallel with the downregulation of osteoblastic RANKL expression. Collectively, LOX-1 abrogation results in resistance to inflammatory bone destruction, despite promoting osteoclastogenesis in the steady state. Our findings indicate the novel involvement of LOX-1 in physiological bone homeostasis and inflammatory bone diseases.

材料
货号
品牌
产品描述

Sigma-Aldrich
甲醛 溶液, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
Sigma-Aldrich
地塞米松, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
甲醛 溶液, for molecular biology, 36.5-38% in H2O
Sigma-Aldrich
地塞米松, ≥98% (HPLC), powder
Sigma-Aldrich
甲醛 溶液, for molecular biology, BioReagent, ≥36.0% in H2O (T)
SAFC
甲醛 溶液, contains 10-15% methanol as stabilizer, 37 wt. % in H2O
Sigma-Aldrich
2-羟基乙基甲基丙烯酸酯, contains ≤250 ppm monomethyl ether hydroquinone as inhibitor, 97%
Sigma-Aldrich
2-羟基乙基甲基丙烯酸酯, ≥99%, contains ≤50 ppm monomethyl ether hydroquinone as inhibitor
Sigma-Aldrich
前列腺素E2, synthetic, powder, BioReagent, suitable for cell culture
Supelco
地塞米松, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
甲醛 溶液, meets analytical specification of USP, ≥34.5 wt. %
Sigma-Aldrich
前列腺素E2, ≥93% (HPLC), synthetic
Sigma-Aldrich
前列腺素E2, γ-irradiated, powder, BioXtra, suitable for cell culture
Supelco
甲醛 溶液, stabilized with methanol, ~37 wt. % in H2O, certified reference material
Sigma-Aldrich
地塞米松, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
甲醛 溶液, tested according to Ph. Eur.
Sigma-Aldrich
地塞米松, meets USP testing specifications
地塞米松, European Pharmacopoeia (EP) Reference Standard
USP
地塞米松, United States Pharmacopeia (USP) Reference Standard
前列腺素E2, European Pharmacopoeia (EP) Reference Standard
地塞米松, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
2-羟基乙基甲基丙烯酸酯, embedding medium (for microscopy)
Sigma-Aldrich
Tetrazolium Violet
Sigma-Aldrich
地塞米松, tested according to Ph. Eur.
Supelco
地塞米松, VETRANAL®, analytical standard
地塞米松, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
凝血酶受体激动剂, ≥97% (HPLC)
地塞米松, British Pharmacopoeia (BP) Assay Standard
Sigma-Aldrich
甲醛-12C 溶液, 20% in H2O, 99.9 atom % 12C